TP53 and non-small cell lung carcinoma: Indeed, bortezomib (BTZ) and other PIs were preferentially cytotoxic in Onc-p53–expressing NSCLC cells which also exhibited higher levels of proteasome activity, indicating that Onc-p53 proteins induce proteotoxic stress.